Richard Nicholas

14.7k total citations · 4 hit papers
178 papers, 8.0k citations indexed

About

Richard Nicholas is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Richard Nicholas has authored 178 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Pathology and Forensic Medicine, 40 papers in Neurology and 34 papers in Neurology. Recurrent topics in Richard Nicholas's work include Multiple Sclerosis Research Studies (116 papers), Neuroinflammation and Neurodegeneration Mechanisms (32 papers) and Peripheral Neuropathies and Disorders (23 papers). Richard Nicholas is often cited by papers focused on Multiple Sclerosis Research Studies (116 papers), Neuroinflammation and Neurodegeneration Mechanisms (32 papers) and Peripheral Neuropathies and Disorders (23 papers). Richard Nicholas collaborates with scholars based in United Kingdom, Italy and United States. Richard Nicholas's co-authors include Richard Reynolds, Roberta Magliozzi, Owain W. Howell, Barbara Serafini, Francesca Aloisi, Federico Roncaroli, Paolo A. Muraro, Maria Puopolo, Cheryl Reeves and Omar Malik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Richard Nicholas

170 papers receiving 7.8k citations

Hit Papers

Meningeal B-cell follicles in secondary progressive multi... 2006 2026 2012 2019 2006 2011 2010 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
    2006 1.1k citations Roberta Magliozzi, Owain W. Howell et al. Brain profile →
  2. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
    2011 630 citations Owain W. Howell, Richard Nicholas et al. Brain profile →
  3. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
    2010 543 citations Roberta Magliozzi, Owain W. Howell et al. Annals of Neurology profile →
  4. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
    2014 304 citations Jeremy Chataway, Richard Nicholas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Nicholas United Kingdom 42 4.7k 2.0k 1.8k 1.8k 1.4k 178 8.0k
Orhan Aktaş Germany 53 4.7k 1.0× 1.7k 0.8× 3.2k 1.8× 1.9k 1.1× 2.6k 1.9× 208 10.4k
Paolo Gallo Italy 48 4.8k 1.0× 1.2k 0.6× 2.2k 1.2× 1.2k 0.7× 945 0.7× 182 7.6k
Martin Stangel Germany 50 2.8k 0.6× 2.5k 1.3× 1.7k 1.0× 1.9k 1.1× 2.3k 1.7× 283 9.1k
David Leppert Switzerland 51 3.8k 0.8× 1.1k 0.6× 2.9k 1.7× 1.6k 0.9× 2.4k 1.8× 170 10.5k
Tobias Derfuß Switzerland 41 3.2k 0.7× 885 0.4× 1.7k 0.9× 2.0k 1.1× 1.4k 1.0× 149 6.6k
Robert J. Fox United States 54 7.9k 1.7× 1.4k 0.7× 2.8k 1.6× 2.6k 1.5× 2.2k 1.6× 310 12.8k
Olaf Stüve United States 57 6.4k 1.3× 1.3k 0.7× 2.6k 1.5× 3.3k 1.9× 1.9k 1.4× 251 11.5k
Finn Sellebjerg Denmark 54 6.0k 1.3× 1.2k 0.6× 2.5k 1.4× 3.4k 1.9× 1.7k 1.3× 315 10.3k
María Trojano Italy 57 8.0k 1.7× 970 0.5× 2.9k 1.6× 1.3k 0.8× 1.6k 1.2× 304 11.3k
Mohsen Khademi Sweden 47 2.6k 0.6× 901 0.5× 1.1k 0.6× 2.5k 1.4× 1.7k 1.3× 130 6.7k

Countries citing papers authored by Richard Nicholas

Since Specialization
Citations

This map shows the geographic impact of Richard Nicholas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Nicholas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Nicholas more than expected).

Fields of papers citing papers by Richard Nicholas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Nicholas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Nicholas. The network helps show where Richard Nicholas may publish in the future.

Co-authorship network of co-authors of Richard Nicholas

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Nicholas. A scholar is included among the top collaborators of Richard Nicholas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Nicholas. Richard Nicholas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papadopoulos, Dimitrios, Roberta Magliozzi, Lesley Probert, et al.. (2025). Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study. Annals of Neurology. 97(6). 1074–1087. 3 indexed citations
2.
3.
Moura, Alexandra, Valentina Giunchiglia, William Trender, et al.. (2025). Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairment. Nature Communications. 16(1). 6938–6938. 1 indexed citations
4.
Muraro, Paolo A., Antonio Zito, Alessio Signori, et al.. (2025). Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study. Annals of Neurology. 98(2). 294–307. 4 indexed citations
5.
Muraro, Paolo A., Eleonora De Matteis, Gavin Brittain, et al.. (2025). Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK. Journal of Neurology Neurosurgery & Psychiatry. 97(2). jnnp–2025.
6.
Varley, James, Rahma Beyrouti, Richard Nicholas, et al.. (2025). A comparison of JC virus assay performance provided with originator and biosimilar natalizumab. Multiple Sclerosis Journal. 31(7). 882–885.
7.
Herranz, Elena, Constantina A. Treaba, Valeria Barletta, et al.. (2024). Characterization of cortico-meningeal translocator protein expression in multiple sclerosis. Brain. 147(7). 2566–2578. 10 indexed citations
8.
Bianchi, Alessia, Rosa Cortese, Ferrán Prados, et al.. (2024). Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein–associated disease. Multiple Sclerosis Journal. 30(6). 674–686. 1 indexed citations
9.
Middleton, Rod, I Farkas, David R. Owen, et al.. (2023). Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older‐Onset Multiple Sclerosis. Annals of Neurology. 95(3). 471–486. 13 indexed citations
10.
Magliozzi, Roberta, Giulia Fadda, Robert A. Brown, et al.. (2022). “Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis. Annals of Neurology. 92(4). 670–685. 36 indexed citations
11.
Dobson, Ruth, Matthew Craner, Aleisha Miller, et al.. (2021). OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. BMJ Open. 11(11). e050176–e050176. 2 indexed citations
12.
Garjani, Afagh, Rachael Hunter, Graham Law, et al.. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register. Multiple Sclerosis Journal. 28(7). 1060–1071. 20 indexed citations
13.
Garjani, Afagh, Rod Middleton, Rachael Hunter, et al.. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Multiple Sclerosis and Related Disorders. 52. 102939–102939. 36 indexed citations
14.
Samjoo, Imtiaz A., Evelyn Worthington, Chris Cameron, et al.. (2020). The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis. Current Medical Research and Opinion. 36(7). 1145–1156. 5 indexed citations
15.
Middleton, Rod, Owen Pearson, Gillian Ingram, et al.. (2020). A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test. Journal of Medical Internet Research. 22(9). e18234–e18234. 13 indexed citations
16.
Samjoo, Imtiaz A., Evelyn Worthington, Chris Cameron, et al.. (2020). Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis. Current Medical Research and Opinion. 36(7). 1157–1166. 13 indexed citations
17.
Middleton, Rod, Arron Lacey, Owen Pearson, et al.. (2019). 030 Automating clinical audit in neurology. Journal of Neurology Neurosurgery & Psychiatry. 90(12). A18.1–A18. 1 indexed citations
18.
Raffel, Joel, Alison E. Wallace, Djordje Gverić, et al.. (2017). Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29. PLoS Medicine. 14(7). e1002346–e1002346. 17 indexed citations
19.
Giannetti, Paolo, Marios Politis, Paul Su, et al.. (2013). Microglia Activation in Clinically Isolated Syndrome: 11C11195PK-PET Change within Normal Appearing White Matter and Deep Grey Matter Structures. UCL Discovery (University College London). 1 indexed citations
20.
Nicholas, Richard & Jeremy Chataway. (2007). Multiple sclerosis.. PubMed. 2007. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orhan Aktaş Breakdown of academic impact, for papers by Paolo Gallo Breakdown of academic impact, for papers by Martin Stangel Breakdown of academic impact, for papers by David Leppert Breakdown of academic impact, for papers by Tobias Derfuß Breakdown of academic impact, for papers by Robert J. Fox Breakdown of academic impact, for papers by Olaf Stüve Breakdown of academic impact, for papers by Finn Sellebjerg Breakdown of academic impact, for papers by María Trojano Breakdown of academic impact, for papers by Mohsen Khademi
Rankless by CCL
2026